Telehealth Cliff
The Telehealth Cliff
The rules that let clinicians prescribe controlled medications by telehealth without an in-person visit are scheduled to expire December 31, and the final replacement rule still isn’t public.
Check your own exposure with a 5-question self-audit, watch our free briefing, and stay ahead of what comes next.
How exposed is your practice?
Five questions, about a minute. For each one, choose who controls it today. Your result appears right away, and nothing is saved or sent.
Answer all five questions
Count your “Me” answers to see how exposed you are if your platform or employer changes course.
- 0–1Exposed
- 2–3Partially exposed
- 4–5Mostly independent
Watch the full briefing
Patrick Brown, PMHNP-BC, Founder & CEO of Modyfi Health, walks through the rule in 60 minutes:
- How we got here, from the Ryan Haight Act to four extensions
- Where the rule stands, and who’s most exposed
- A three-step plan you can start now
Six years of temporary rules end in one day.
Since 2020, clinicians have relied on a series of temporary extensions. The current one runs out December 31.
- 2008The Ryan Haight Act requires an in-person evaluation before prescribing controlled substances over the internet, with limited exceptions.
- 2020The COVID-19 public health emergency lets DEA-registered clinicians prescribe by telehealth without that in-person visit.
- Jan 2025The DEA proposes a telemedicine special registration and finalizes separate final rules governing buprenorphine treatment and certain VA telemedicine encounters.
- Dec 2025After three earlier extensions, the DEA issues a fourth, running through December 31, 2026.
- Aug 2026The final special registration rule goes to the White House for review. Its text isn’t public yet.
- Dec 31, 2026The current temporary flexibilities are scheduled to expire. What replaces them depends on what the final rule says and when it takes effect.
Who should pay close attention
You may be most exposed if you…
- Prescribe stimulants, benzodiazepines or other controlled medications to patients you’ve only seen by video
- Run a fully virtual practice with no physical location for in-person visits
- See patients in more than one state
- Started patients on controlled medications by telehealth since 2020 and have no in-person evaluation on file
- Work with or for a telehealth platform that prescribes controlled substances
Who it’s for
This is especially relevant to psychiatric and behavioral health practices, where controlled medications are a core part of care. Anyone whose patients depend on telehealth prescribing is welcome.
Don’t find out on January 1.
Get updates as the DEA rule develops, and the first invite to our next session.
This information is for educational purposes only and is not legal advice. For decisions about your own practice, talk with your own healthcare attorney or compliance advisor. It reflects publicly available information as of November 2026. Rules and timelines may change.
need help?
Reach out to us today. Text, call, or email us.